Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Oyster point pharma | Vintage Vibes

3 Stocks to Buy With Less Than $10

The recent collapse of two banks and growing uncertainty about the Fed’s next rate hike amid the strong economic data releases fueled a broad market sell-off lately. However, a volatile market environment offers an attractive opportunity to invest in quality stocks ADT (ADT), Viatris (VTRS), and trivago (TRVG) at reasonable…

StockNews.com · Mar 20, 2023

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022

Upgrades

Benzinga · Nov 8, 2022

Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday

U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.

Benzinga · Nov 8, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

Benzinga · Nov 7, 2022

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Benzinga · Nov 7, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga · Jul 20, 2022

Oyster Point Outlines Restructuring Plan With Savings Of Up To $48M In 2023

Oyster Point Pharma Inc (NASDAQ:OYST) will implement an operating expense streamlining plan to reduce employee and non-employee expenses (up to 50 roles) across the organization. The company plans to continue to drive the launch of Tyrvaya with approximately 150-200 field-based sales resources. The plan is expected to reduce operating expenses by approximately $6…

Benzinga · Jun 29, 2022

Read news from The Economist, FT, and more,
with one subscription

Earnings Preview: Oyster Point Pharma

Oyster Point Pharma (NASDAQ:OYST) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Oyster Point Pharma will report an earnings per share (EPS) of $-1.74.

Benzinga · May 4, 2022

Coverage From

People

Donald Trump

214,910 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Digital World Acquisition Corp

34 stories

SolarEdge Technologies

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.